Ann‐Kathrin Eisfeld

2.6k citations

64 papers · 1.0k indexed · h-index 19

Hematology top 2%
Molecular Biology
Cancer Research top 10%
Genetics top 5%
Public Health, Environmental and Occupational Health top 10%

Co-authors: Clara D. Bloomfield Richard M. Stone Jessica Kohlschmidt Krzysztof Mrózek Deedra Nicolet Jonathan E. Kolitz Andrew J. Carroll John C. Byrd
Topics: Acute Myeloid Leukemia Research (41 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers)Chronic Myeloid Leukemia Treatments (11 papers)
Cited by: Hematology Cancer Research Genetics
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Oncology Blood
Partner nations: United States Germany Italy

In The Last Decade

Ann‐Kathrin Eisfeld

57 papers receiving 1.0k citations

Peers

Countries citing papers authored by Ann‐Kathrin Eisfeld

Since Specialization

Citations

This map shows the geographic impact of Ann‐Kathrin Eisfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Kathrin Eisfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Kathrin Eisfeld more than expected).

Fields of papers citing papers by Ann‐Kathrin Eisfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann‐Kathrin Eisfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Kathrin Eisfeld. The network helps show where Ann‐Kathrin Eisfeld may publish in the future.

Co-authorship network of co-authors of Ann‐Kathrin Eisfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Ann‐Kathrin Eisfeld. A scholar is included among the top collaborators of Ann‐Kathrin Eisfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann‐Kathrin Eisfeld. Ann‐Kathrin Eisfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies 2025 ·Leukemia ·(unknown),Deedra Nicolet,(unknown),Daelynn R. Buelow,Shelley Orwick,Charles T. Gregory,(unknown),(unknown),Jonathan E. Kolitz,Bayard L. Powell,William Blum,Maria R. Baer,John C. Byrd,Wendy Stock,Geoffrey L. Uy,Krzysztof Mrózek,Ann‐Kathrin Eisfeld,Xiaolin Cheng,Sharyn D. Baker,James S. Blachly	1
2	Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia 2024 ·The Innovation ·Kellie J. Archer,(unknown),Krzysztof Mrózek,Deedra Nicolet,Alice S. Mims,Geoffrey L. Uy,Wendy Stock,John C. Byrd,Wolfgang Hiddemann,Klaus H. Metzeler,Christian Rausch,Utz Krug,Cristina Sauerland,Dennis Görlich,Wolfgang E. Berdel,Bernhard J. Woermann,Jan Braess,Karsten Spiekermann,Tobias Herold,Ann‐Kathrin Eisfeld	1
3	Association of social deprivation with survival in younger adult patients with AML: an Alliance study 2023 ·Blood Advances ·(unknown),Jessica Kohlschmidt,Krzysztof Mrózek,Deedra Nicolet,Alice S. Mims,James S. Blachly,Shelley Orwick,Karilyn Larkin,Christopher C. Oakes,Andrew Hantel,Andrew J. Carroll,William Blum,Bayard L. Powell,Geoffrey L. Uy,Richard M. Stone,Richard A. Larson,John C. Byrd,Electra D. Paskett,Jesse J. Plascak,Ann‐Kathrin Eisfeld	5
4	Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study 2023 ·Leukemia ·Krzysztof Mrózek,Jessica Kohlschmidt,James S. Blachly,Deedra Nicolet,Andrew J. Carroll,Kellie J. Archer,Alice S. Mims,Karilyn Larkin,Shelley Orwick,Christopher C. Oakes,Jonathan E. Kolitz,Bayard L. Powell,William Blum,Guido Marcucci,Maria R. Baer,Geoffrey L. Uy,Wendy Stock,John C. Byrd,Ann‐Kathrin Eisfeld	31
5	Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study 2023 ·Blood Advances ·Bhavana Bhatnagar,Jessica Kohlschmidt,Shelley Orwick,Daelynn R. Buelow,(unknown),Christopher C. Oakes,Jonathan E. Kolitz,Geoffrey L. Uy,Wendy Stock,Bayard L. Powell,Deedra Nicolet,Erin Hertlein,Krzysztof Mrózek,James S. Blachly,Ann‐Kathrin Eisfeld,Sharyn D. Baker,John C. Byrd	1
6	Impact of Cytarabine Pharmacogenomics on Survival of Adolescent and Young Adults with AML and Its Clinical Relevance in Black Patients 2023 ·Blood ·(unknown),Deedra Nicolet,(unknown),Krzysztof Mrózek,Christopher J. Walker,William Blum,Bayard L. Powell,Jonathan E. Kolitz,Joseph O. Moore,Geoffrey L. Uy,Wendy Stock,Andrew J. Carroll,John C. Byrd,Ann‐Kathrin Eisfeld,Jatinder K. Lamba	0
7	Impact ofIDH1andIDH2mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation 2022 ·Blood Advances ·Marius Bill,Madlen Jentzsch,(unknown),Jessica Kohlschmidt,Juliane Grimm,(unknown),(unknown),(unknown),(unknown),Georg‐Nikolaus Franke,Vladan Vučinić,Dietger Niederwieser,Alice S. Mims,Uwe Platzbecker,Ann‐Kathrin Eisfeld,Sebastian Schwind	22
8	Molecular and Clinical Features of FLT3 Juxtamembrane Domain Point Mutations (muts) in Acute Myeloid Leukemia (AML) 2022 ·Blood ·(unknown),Jessica Kohlschmidt,Daelynn R. Buelow,Shelley Orwick,(unknown),Krzysztof Mrózek,Jonathan E. Kolitz,Bayard L. Powell,William Blum,Maria R. Baer,John C. Byrd,Wendy Stock,Geoffrey L. Uy,Ann‐Kathrin Eisfeld,Sharyn D. Baker,James S. Blachly	1
9	Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years 2020 ·Leukemia ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Alice S. Mims,Deedra Nicolet,Christopher J. Walker,James S. Blachly,Andrew J. Carroll,Dimitrios Papaioannou,Jonathan E. Kolitz,(unknown),Richard M. Stone,Albert de la Chapelle,John C. Byrd,Krzysztof Mrózek,Clara D. Bloomfield	56
10	Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study 2019 ·Frontiers in Oncology ·(unknown),Yiqian Liu,Ann‐Kathrin Eisfeld,Fuxi Zhen,Shidai Jin,Wen Gao,Tongfu Yu,Liang Chen,Wei Wang,Wei Chen,Mingming Yuan,Rongrong Chen,Kai He,Renhua Guo	35
11	Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia 2019 ·Haematologica ·Marius Bill,Deedra Nicolet,Jessica Kohlschmidt,Christopher J. Walker,Krzysztof Mrózek,Ann‐Kathrin Eisfeld,Dimitrios Papaioannou,Xiaoqing Rong,(unknown),Jonathan E. Kolitz,Bayard L. Powell,Kellie J. Archer,Adrienne M. Dorrance,Andrew J. Carroll,Richard M. Stone,John C. Byrd,Ramiro Garzon,Clara D. Bloomfield	13
12	Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21 2019 ·Leukemia ·Bhavana Bhatnagar,Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Deedra Nicolet,Dimitrios Papaioannou,Christopher J. Walker,Shelley Orwick,James S. Blachly,Jonathan E. Kolitz,Bayard L. Powell,Andrew J. Carroll,Richard M. Stone,John C. Byrd,Clara D. Bloomfield	5
13	NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome 2018 ·Leukemia ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Alice S. Mims,Christopher J. Walker,James S. Blachly,Deedra Nicolet,Shelley Orwick,(unknown),Andrew J. Carroll,Bayard L. Powell,Jonathan E. Kolitz,Eunice S. Wang,Richard M. Stone,Albert de la Chapelle,John C. Byrd,Clara D. Bloomfield	31
14	Neurofibromin 1 gene Mutations Are Recurrent Events in Adult Patients with Acute Myeloid Leukemia (AML), Associate with Poor Outcome and Refine the Adverse European Leukemianet (ELN) Risk Category 2017 ·Blood ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Alice S. Mims,Christopher J. Walker,James S. Blachly,Deedra Nicolet,Shelley Orwick,(unknown),Andrew J. Carroll,Bayard L. Powell,Jonathan E. Kolitz,Eunice S. Wang,Richard M. Stone,Albert de la Chapelle,John C. Byrd,Clara D. Bloomfield	0
15	Mutation Patterns Identify Adult Patients with De Novo Acute Myeloid Leukemia (AML) Aged 60 Years or Older Who Respond Favorably to Standard Chemotherapy: an Analysis of Alliance Studies 2017 ·Blood ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,James S. Blachly,Christopher J. Walker,Deedra Nicolet,Shelley Orwick,Andrew J. Carroll,Richard M. Stone,Eunice S. Wang,Jonathan E. Kolitz,Bayard L. Powell,Albert de la Chapelle,John C. Byrd,Clara D. Bloomfield	0
16	Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality 2016 ·Cancer Research ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Stefano Volinia,James S. Blachly,Deedra Nicolet,Christopher C. Oakes,(unknown),Shelley Orwick,Andrew J. Carroll,Richard M. Stone,John C. Byrd,Albert de la Chapelle,Clara D. Bloomfield	16
17	Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia 2016 ·Cancer Discovery ·(unknown),Christopher J. Walker,Sandya Liyanarachchi,(unknown),(unknown),(unknown),Xiaomeng Huang,(unknown),(unknown),Parvathi Ranganathan,Ramiro Garzon,James S. Blachly,Denis C. Guttridge,Clara D. Bloomfield,Albert de la Chapelle,Ann‐Kathrin Eisfeld	13
18	MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch Repair 2016 ·Human Mutation ·Christopher J. Walker,(unknown),(unknown),James S. Blachly,(unknown),Jennifer Ivanovich,(unknown),Ann‐Kathrin Eisfeld,(unknown),David G. Mutch,David E. Cohn,Ralf Bundschuh,Paul J. Goodfellow	5
19	Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia 2016 ·British Journal of Haematology ·Bhavana Bhatnagar,Ann‐Kathrin Eisfeld,Deedra Nicolet,Krzysztof Mrózek,James S. Blachly,Shelley Orwick,David Lucas,Jessica Kohlschmidt,William Blum,Jonathan E. Kolitz,Richard M. Stone,Clara D. Bloomfield,John C. Byrd	41
20	Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia 2013 ·Leukemia & lymphoma ·(unknown),Simona Iacobelli,Sabine Leiblein,Ann‐Kathrin Eisfeld,Christian Pfrepper,Simone Heyn,Vladan Vučinić,Georg‐Nikolaus Franke,Rainer Krahl,Stephan Fricke,Cornelia Becker,Wolfram Pönisch,Gerhard Behre,Dietger Niederwieser,Thoralf Lange	3

About Ann‐Kathrin Eisfeld

Ann‐Kathrin Eisfeld is a scholar working on Hematology, Genetics and Cancer Research, having authored 64 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (41 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Chronic Myeloid Leukemia Treatments (11 papers). The work is most often cited by research in Hematology (563 citations), Cancer Research (303 citations) and Genetics (193 citations). Ann‐Kathrin Eisfeld has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Clara D. Bloomfield, Richard M. Stone, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Jonathan E. Kolitz, Andrew J. Carroll, John C. Byrd, Bayard L. Powell and James S. Blachly. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact